Historically, success in pinpointing the microenvironmental contributions to soft tissue sarcoma progression, especially during the onset of sarcoma, has proven elusive.
Meet StageBio’s featured team member, Dr Timothy Cooper, in December’s spotlight and his recent accomplishments in medical device work.
Established by the merger of industry leaders, StageBio is an integrated partner serving the full spectrum of your histopathology needs. Our experienced team of laboratory staff, board-certified pathologists and archiving specialists are both experts in their respective fields and stewards of your projects’ success.
StageBio expands its capabilities on both sides of the Atlantic with the acquisition of TPL Path Labs.